Lachine, Canada

Wang Zhigang

This inventor holds 1 USPTO granted patent. Top assignee: Taimed Biologics, Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wang Zhigang. Retrieved from https://idiyas.com/inventor/wang-zhigang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wang Zhigang: Innovator in HIV Research

Introduction

Wang Zhigang is a notable inventor based in Lachine, Canada. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds aimed at combating HIV.

Latest Patents

Wang Zhigang holds a patent for "HIV integrase inhibitors from pyridoxine." This invention relates to pyridoxine (vitamin B) derived compounds that inhibit the Human Immunodeficiency Virus (HIV)-integrase enzyme. The compounds are useful for preventing and treating HIV infection and AIDS. His patent includes pharmaceutically acceptable salts or solvates of the compounds, which are defined in the specification.

Career Highlights

Wang Zhigang is associated with Taimed Biologics, Inc., where he continues to work on innovative solutions for health challenges. His research focuses on developing effective treatments for viral infections, showcasing his commitment to improving public health.

Collaborations

Wang has collaborated with notable colleagues, including Brent Richard Stranix and Francis Beaulieu, to advance his research and patent developments.

Conclusion

Wang Zhigang's work in developing HIV integrase inhibitors represents a significant advancement in the fight against HIV and AIDS. His contributions to the field highlight the importance of innovation in pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…